---
title: "David Liu的Chroma&Nvelop决定合并"
date: 2024-12-16T00:13:15Z
draft: ["false"]
tags: [
  "fetched",
  "循因缉药"
]
categories: ["Acdemic"]
---
David Liu的Chroma&Nvelop决定合并 by 循因缉药
------
<div><p data-mpa-powered-by="yiban.io"><strong><span>环球视野，深度视角</span></strong></p><section><mp-common-profile data-pluginname="mpprofile" data-id="MzU3OTYwNjk1NA==" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxTpdnicXDtfPzgiaP26T8ecl3Nr7jK6CbzxybDQfqicvlKsfI6AmGbkuoydTicXtqPbwh6e6MStGn3tyPQ/300?wx_fmt=png&amp;wxfrom=19" data-nickname="循因缉药" data-alias="Gene-Med" data-signature="前沿基因科技、创新药物研发深度吃瓜，拒做复读机，从我做起。" data-from="2" data-origin_num="962" data-isban="0" data-biz_account_status="0" data-index="0" data-is_biz_ban="0"></mp-common-profile></section><section><span>各位亲爱的股东，大家早上好中午好晚上好。</span></section><p>昨天，我们聊了Editas。</p><p>其实在这之前，另一位基因编辑界的大佬David Liu 刘如谦所创建的两家公司先动手了。</p><section data-mpa-template="t" mpa-from-tpl="t"><section mpa-from-tpl="t"><section mpa-from-tpl="t"><section data-width="100%" mpa-from-tpl="t"><section data-preserve-color="t" mpa-from-tpl="t"><section data-role="width" mpa-from-tpl="t"><img border="0" data-imgfileid="100034402" data-ratio="0.8571428571428571" data-src="https://mmbiz.qpic.cn/mmbiz_png/fgnkxfGnnkQHrbiaR05ibWjdTib5rVzbZRE7f8VcgckIV4tiaVMvquMYiaQkJj2VfdGuO34ZTGqIqqjzMkDfEsbx9TA/640?wx_fmt=png" data-w="35" height="" width="2rem" src="https://mmbiz.qpic.cn/mmbiz_png/fgnkxfGnnkQHrbiaR05ibWjdTib5rVzbZRE7f8VcgckIV4tiaVMvquMYiaQkJj2VfdGuO34ZTGqIqqjzMkDfEsbx9TA/640?wx_fmt=png"></section></section></section><section data-preserve-color="t" mpa-from-tpl="t"><p mpa-is-content="t">“开公司走不到你（张锋）前头，合并还走不到你前头吗？”</p></section></section></section></section><p><br></p><p>可恶，被他装到了。</p><p><strong>这两家公司就是表观基因编辑技术公司Chroma Medicine和类病毒基因编辑递送技术公司Nvelop Therapeutics。</strong></p><p><img data-imgfileid="100034404" data-ratio="0.5657407407407408" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BFBVntoObahWK10Yibibt9or9A0kgUYANkJlzia35l9M1YYCSlgfibtU4uA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BFBVntoObahWK10Yibibt9or9A0kgUYANkJlzia35l9M1YYCSlgfibtU4uA/640?wx_fmt=png&amp;from=appmsg"></p><p><strong>2024年12月11日，这两家公司宣布合并成一家新公司nChroma Bio。</strong></p><p>同时，nChroma Bio获得了由Cormorant Asset Management、Arch Venture Partners等<strong>领投的7500万美元融资。</strong></p><p><img data-imgfileid="100034403" data-ratio="0.2962962962962963" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5B8Fa0pa4EiabcwNUKrRTTRpEDykfSYXY93LpMhpjiafxrhI5wmCtwCfMg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5B8Fa0pa4EiabcwNUKrRTTRpEDykfSYXY93LpMhpjiafxrhI5wmCtwCfMg/640?wx_fmt=png&amp;from=appmsg"></p><p>合并后，<strong>Nvelop的CEO Jeff Walsh将担任新公司的CEO，Chroma原CEO Catherine Stehman-Breen将担任公司顾问（出局）。</strong></p><p>公司将推进Chroma针对慢性乙型肝炎和丁型肝炎的核心资产CRMA-1001，目标是在2025年提交临床试验申请，2026年完成首批患者给药，获得首批临床数据。</p><p><img data-imgfileid="100034406" data-ratio="0.6398148148148148" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BKDdubkomCL88ic7cBIF1BTWcHmsZvWicbC76XibpObVcSagzLR8YqI1xQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BKDdubkomCL88ic7cBIF1BTWcHmsZvWicbC76XibpObVcSagzLR8YqI1xQ/640?wx_fmt=png&amp;from=appmsg"></p><p><span><strong>Chroma和Nvelop走的太突然，甚至都没来得及上我们的“死亡笔记”。</strong></span></p><p>不过，我们还是要大概介绍下这两家公司。</p><p><br mpa-from-tpl="t"></p><section data-mpa-template="t" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid="">#01</p></section><section data-mid="" mpa-from-tpl="t"><p data-mid=""><strong>Chroma</strong></p></section></section></section></section></section><p>Chroma Medicine，成立于2021年11月，总部位于波士顿。</p><p><strong>公司由David Liu、Keith Joung等多位科学家创立，意图通过表观遗传编辑器、利用细胞的先天基因调控机制，使用单一平台精确、持久地沉默、激活基因，而无需改变DNA序列。</strong></p><p>根据crunchbase的记录，早在2020年团队就拿到了<strong>Newpath Management和Atlas Venture的种子轮融资。</strong></p><p>最近在2023年3月1日，获得了来自Google Venture领投的1.35亿美元融资，<span><strong>合计融资规模达到2.6亿美元以上。</strong></span></p><p><img data-imgfileid="100034405" data-ratio="0.4212962962962963" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BBLibN5ZJIOU5JU2V6icicG3NESlFAueWsx9iaSRHw93ESKPwXMbdZyp4OA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BBLibN5ZJIOU5JU2V6icicG3NESlFAueWsx9iaSRHw93ESKPwXMbdZyp4OA/640?wx_fmt=png&amp;from=appmsg"></p><p>CRMA-1001是一种表观遗传修饰剂，<strong>它通过向病毒的DNA中添加甲基来沉默肝炎病毒中的基因表达，而无需对DNA分子本身进行任何切割或编辑。</strong></p><p><strong>这种表观遗传修饰剂既可以与HBV的cccDNA结合，又可以沉默整合进基因组的HBV DNA的表达。</strong></p><p><img data-imgfileid="100034407" data-ratio="0.4305555555555556" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BJsia8I3icdbq5F5PDhf8stkqsHf3heJq84L7OlNx1nPbMMpqP6W5RQMg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BJsia8I3icdbq5F5PDhf8stkqsHf3heJq84L7OlNx1nPbMMpqP6W5RQMg/640?wx_fmt=png&amp;from=appmsg"></p><p><strong>CRMA-1001通过脂质纳米颗粒（LNPs）递送</strong>，可持久防止HBV DNA和病毒生物标志物反弹，从而达到<span><strong>功能性治愈。</strong></span></p><p><strong><br mpa-from-tpl="t"></strong></p><section data-mpa-template="t" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid="">#02</p></section><section data-mid="" mpa-from-tpl="t"><p data-mid=""><strong><strong>Nvelop</strong></strong></p></section></section></section></section></section><p><br></p><p><img data-imgfileid="100034411" data-ratio="0.5916666666666667" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BMWHIJEibv7j06QOB58OoTMBZaiaTz5oeK694lg4tB09RMkTsKv1BfTbg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BMWHIJEibv7j06QOB58OoTMBZaiaTz5oeK694lg4tB09RMkTsKv1BfTbg/640?wx_fmt=png&amp;from=appmsg"></p><p>Nvelop成立于2022年，总部位于波士顿。</p><p>公司创始人Keith Joung和David Liu，<strong>2023年获得来自Newpath Management领投的1亿美元种子轮融资。</strong></p><p><img data-imgfileid="100034409" data-ratio="0.375" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BcIvtkicmo6zjneNZHUQOJ5RV5a1W5vvtQAA4Nq71ibcH3LekJ1gB22Lg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BcIvtkicmo6zjneNZHUQOJ5RV5a1W5vvtQAA4Nq71ibcH3LekJ1gB22Lg/640?wx_fmt=png&amp;from=appmsg"></p><p><strong>Nvelop开发的是工程化的类病毒颗粒（Virus-like particle，VLP），能够高效递送碱基编辑系统和先导编辑系统载荷。</strong></p><p><img data-imgfileid="100034408" data-ratio="0.3398148148148148" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5B9dGIgibGX5UUA1tMiaomibXLGZteOmQF5VicRQAjm37DRLOJP08fsiczOyQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5B9dGIgibGX5UUA1tMiaomibXLGZteOmQF5VicRQAjm37DRLOJP08fsiczOyQ/640?wx_fmt=png&amp;from=appmsg"></p><p>目前，公司有DLVR-X和DLVR-M两个技术平台。</p><p><strong><br mpa-from-tpl="t"></strong></p><section data-mpa-template="t" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid="">#03</p></section><section data-mid="" mpa-from-tpl="t"><p data-mid=""><strong>最大输家</strong></p></section></section></section></section></section><p><br></p><p><img data-imgfileid="100034410" data-ratio="0.2037037037037037" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BFHzZMUBjGGNT1NuRfAibTWhz8G9dOicm4SE3sycquEEIAvaC7DqDYvsA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BFHzZMUBjGGNT1NuRfAibTWhz8G9dOicm4SE3sycquEEIAvaC7DqDYvsA/640?wx_fmt=png&amp;from=appmsg"></p><p><strong>根据FireceBio的报道，两家公司的合并始于9月25日在Chroma办公室附近的Bar Taco的一次聊天。</strong></p><p>在吃了一顿taco后，两家公司CEO觉得公司之间有很深的“羁绊”，有很强的协同潜力。</p><p>废话...创始人都是一样的，种子轮都是Newpath投的，能不“羁绊”吗？</p><p><strong>所以，最大的输家是Starbucks咯？</strong><span></span></p><section data-mpa-template="t" mpa-from-tpl="t"><section mpa-from-tpl="t"><section mpa-from-tpl="t"><section data-width="100%" mpa-from-tpl="t"><section data-preserve-color="t" mpa-from-tpl="t"><section data-role="width" mpa-from-tpl="t"><img border="0" data-imgfileid="100034412" data-ratio="0.8571428571428571" data-src="https://mmbiz.qpic.cn/mmbiz_png/fgnkxfGnnkQHrbiaR05ibWjdTib5rVzbZRE7f8VcgckIV4tiaVMvquMYiaQkJj2VfdGuO34ZTGqIqqjzMkDfEsbx9TA/640?wx_fmt=png" data-w="35" height="" width="2rem" src="https://mmbiz.qpic.cn/mmbiz_png/fgnkxfGnnkQHrbiaR05ibWjdTib5rVzbZRE7f8VcgckIV4tiaVMvquMYiaQkJj2VfdGuO34ZTGqIqqjzMkDfEsbx9TA/640?wx_fmt=png"></section></section></section><section data-preserve-color="t" mpa-from-tpl="t"><p mpa-is-content="t">“谈并购我只去吃taco，喝咖啡都不好意思跟人家开口！”</p></section></section></section></section><p><br></p><p><img data-imgfileid="100034415" data-ratio="0.27870370370370373" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BeHjxu9fBcaWVTiciafBib80oMwf4rKgpb1MLIPicfDmbCeZT0Dia4cggw2w/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5BeHjxu9fBcaWVTiciafBib80oMwf4rKgpb1MLIPicfDmbCeZT0Dia4cggw2w/640?wx_fmt=png&amp;from=appmsg"></p><p><strong>另外，两家公司也进行了裁员。</strong></p><p>新CEO拒绝透露裁员数量，但是，万能的网友表示：</p><p><span><strong>裁员比例：30% Chroma + 30% Nvelop。</strong></span></p><p>另外，<strong>该名网友表示Chroma和Nvlop向社会输送了大量优秀基因编辑和递送技术人才。</strong></p><p>朋友，明天来公关部上班！</p><p><strong><br mpa-from-tpl="t"></strong></p><section data-mpa-template="t" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid="">#04</p></section><section data-mid="" mpa-from-tpl="t"><p data-mid="">最后<br></p></section></section></section></section></section><p><br></p><p><img data-imgfileid="100034416" data-ratio="0.39166666666666666" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5Bcriaic1UGcEOYwTk84fNzTMo0HBv38q1EgweU93d3W744XcU4ZqlkyYg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToKgb5ibqVeknyrZWGd9PP5Bcriaic1UGcEOYwTk84fNzTMo0HBv38q1EgweU93d3W744XcU4ZqlkyYg/640?wx_fmt=png&amp;from=appmsg"></p><p>Newpath是真喜欢基因编辑啊...除了这两家，他们还投了ERA Therapetics（张锋co-founder）和Exo Therapeutics（David Liu co-founder）和Prime Medicine（David Liu co-founder）。</p><p>可以说非常执着了。</p><p><span><strong>哦，对了，CRMA-1001的递送工具是脂质纳米颗粒（LNPs），也不知道怎么跟Nvlop协同。</strong></span></p><section data-mpa-template="t" mpa-from-tpl="t"><section data-mpa-template="t" data-mpa-template-id="383" data-mpa-category="模板" mpa-from-tpl="t"><section data-mpa-category="模板" data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid="">END</p></section></section></section></section><section data-mpa-template="t" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><img data-imgfileid="100034413" data-ratio="0.9902912621359223" data-w="412" data-src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToOeEMcaJhfIv0PGhthDHPvF2EtJcJVNuCa5Ay8ES6HEfzD7J9mhW449OdW3HxyXrqbgRKVgtaHpA/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" src="https://mmbiz.qpic.cn/mmbiz_png/icugQvAnqxToOeEMcaJhfIv0PGhthDHPvF2EtJcJVNuCa5Ay8ES6HEfzD7J9mhW449OdW3HxyXrqbgRKVgtaHpA/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></section><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid=""><br></p></section><section data-mid="" mpa-from-tpl="t"><p data-mid="">啊对对对对，<span>扫描这货</span></p><p data-mid=""><span>能联系到我</span></p></section></section></section></section></section></section></section></section><p>至此，各位股东星标了么？点赞了么？转发了么？在看了么？谢谢！<img data-ratio="1" data-src="https://res.wx.qq.com/t/wx_fed/we-emoji/res/v1.3.10/assets/Expression/Expression_45@2x.png" data-w="128" src="https://res.wx.qq.com/t/wx_fed/we-emoji/res/v1.3.10/assets/Expression/Expression_45@2x.png"></p><p>所有内容均不作为投资建议，信息均来自公开资料。</p><p><strong>近期文章：</strong></p><section data-mpa-template="t" data-from="yb-recommend-list"><section data-mpa-template="t" data-from="yb-recommend" data-recommend-article-type="normal" data-recomment-template-id="1" data-recommend-article-id="1000001116_1" data-recommend-article-time="1734105600" data-recommend-article-cover="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTrXDy0oGKHsm4fmrvnFAdZGxfuWa1S6ymGtMVYURCtSiaWibSIWdV9ePtKMLzsSkAor8ZEJtwn71lDg/0?wx_fmt=jpeg" data-recommend-article-title="Editas：天塌了" data-recommend-article-content-url="https://mp.weixin.qq.com/s/uSIiaIPaSZIQkbGnxGN5_A"><a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247518008&amp;idx=1&amp;sn=ac72a671e659038d670092e50c105b63&amp;scene=21#wechat_redirect" data-linktype="1"><section data-recommend-type="normal" data-recommend-tid="1" data-mid=""><section data-mid=""><section data-mid=""><span><img data-imgfileid="100034414" data-ratio="0.42592592592592593" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTrXDy0oGKHsm4fmrvnFAdZGxfuWa1S6ymGtMVYURCtSiaWibSIWdV9ePtKMLzsSkAor8ZEJtwn71lDg/640?wx_fmt=jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTrXDy0oGKHsm4fmrvnFAdZGxfuWa1S6ymGtMVYURCtSiaWibSIWdV9ePtKMLzsSkAor8ZEJtwn71lDg/640?wx_fmt=jpeg"></span></section><section data-mid=""><p data-recommend-title="t" data-mid="">Editas：天塌了</p></section></section></section></a></section><br><section data-mpa-template="t" data-from="yb-recommend" data-recommend-article-type="normal" data-recomment-template-id="1" data-recommend-article-id="1000001115_1" data-recommend-article-time="1734048000" data-recommend-article-cover="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTr63WtRxiazHPRKAXRHCqeB3kXJXER4KicrGjDubdDn7gm9SjPaMQtvAKwajonUXdj9WB0aqXVIEPaw/0?wx_fmt=jpeg" data-recommend-article-title="Akoya押注临床，空间生物学求突破" data-recommend-article-content-url="https://mp.weixin.qq.com/s/No1rCWjHE3b32mizwNEr3g"><a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247517989&amp;idx=1&amp;sn=709d762fa437c96178e7b5f3897e2cd7&amp;scene=21#wechat_redirect" data-linktype="1"><section data-recommend-type="normal" data-recommend-tid="1" data-mid=""><section data-mid=""><section data-mid=""><span><img data-imgfileid="100034419" data-ratio="0.42592592592592593" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTr63WtRxiazHPRKAXRHCqeB3kXJXER4KicrGjDubdDn7gm9SjPaMQtvAKwajonUXdj9WB0aqXVIEPaw/640?wx_fmt=jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTr63WtRxiazHPRKAXRHCqeB3kXJXER4KicrGjDubdDn7gm9SjPaMQtvAKwajonUXdj9WB0aqXVIEPaw/640?wx_fmt=jpeg"></span></section><section data-mid=""><p data-recommend-title="t" data-mid="">Akoya押注临床，空间生物学求突破</p></section></section></section></a></section><br><section data-mpa-template="t" data-from="yb-recommend" data-recommend-article-type="normal" data-recomment-template-id="1" data-recommend-article-id="1000001114_1" data-recommend-article-time="1733965200" data-recommend-article-cover="https://mmbiz.qpic.cn/sz_mmbiz_jpg/wuJWmthFv851a7C2soYqibJ4icWB80fpicPPYVI3395I5NBbzdjEfKAzluHkmBqwHNet8DLoFic41txAS9alqDXjYg/0?wx_fmt=jpeg" data-recommend-article-title="普译生物发布PolyseqHive，中通量纳米孔测序多了一个选择！" data-recommend-article-content-url="https://mp.weixin.qq.com/s/f0asHJTa8pOq7b7QzPh-0g"><a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247517956&amp;idx=1&amp;sn=e89abfcf167fa66ee91c2aaa19c89e72&amp;scene=21#wechat_redirect" data-linktype="1"><section data-recommend-type="normal" data-recommend-tid="1" data-mid=""><section data-mid=""><section data-mid=""><span><img data-imgfileid="100034417" data-ratio="0.42597402597402595" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/wuJWmthFv851a7C2soYqibJ4icWB80fpicPPYVI3395I5NBbzdjEfKAzluHkmBqwHNet8DLoFic41txAS9alqDXjYg/640?wx_fmt=jpeg" data-w="770" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/wuJWmthFv851a7C2soYqibJ4icWB80fpicPPYVI3395I5NBbzdjEfKAzluHkmBqwHNet8DLoFic41txAS9alqDXjYg/640?wx_fmt=jpeg"></span></section><section data-mid=""><p data-recommend-title="t" data-mid="">普译生物发布PolyseqHive，中通量纳米孔测序多了一个选择！</p></section></section></section></a></section><br><section data-mpa-template="t" data-from="yb-recommend" data-recommend-article-type="normal" data-recomment-template-id="1" data-recommend-article-id="1000001113_1" data-recommend-article-time="1733875200" data-recommend-article-cover="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTrWckm3T5tLX3ReVoU5aEjGLxvxOX80ibKPXQ6xlibVick9CGoeQ48LhltQvJ2CuvkBozH51QVQvxdBQ/0?wx_fmt=jpeg" data-recommend-article-title="Myriad核心业务面临挑战" data-recommend-article-content-url="https://mp.weixin.qq.com/s/pwKxl3UTAxpRWVJyQ4dGiQ"><a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247517947&amp;idx=1&amp;sn=82d333b27aa20b9787bc6a9e03eb5abd&amp;scene=21#wechat_redirect" data-linktype="1"><section data-recommend-type="normal" data-recommend-tid="1" data-mid=""><section data-mid=""><section data-mid=""><span><img data-imgfileid="100034421" data-ratio="0.425" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTrWckm3T5tLX3ReVoU5aEjGLxvxOX80ibKPXQ6xlibVick9CGoeQ48LhltQvJ2CuvkBozH51QVQvxdBQ/640?wx_fmt=jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTrWckm3T5tLX3ReVoU5aEjGLxvxOX80ibKPXQ6xlibVick9CGoeQ48LhltQvJ2CuvkBozH51QVQvxdBQ/640?wx_fmt=jpeg"></span></section><section data-mid=""><p data-recommend-title="t" data-mid="">Myriad核心业务面临挑战</p></section></section></section></a></section><br><section data-mpa-template="t" data-from="yb-recommend" data-recommend-article-type="normal" data-recomment-template-id="1" data-recommend-article-id="1000001112_1" data-recommend-article-time="1733788800" data-recommend-article-cover="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTqjBp2JibLbUv4KBicZiac1iaHBI7PXrI7jp2PXtdJfe1aJHZmamlVwVr8BeT3kLGqCkfMMia1YhxrQ4AA/0?wx_fmt=jpeg" data-recommend-article-title="中美两国联手，给华大智造们送了一个大礼包" data-recommend-article-content-url="https://mp.weixin.qq.com/s/e-8qQgteJaTiQr6J1Ox_Tw"><a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247517908&amp;idx=1&amp;sn=007dee364d034ba29f64616c9b0a1670&amp;scene=21#wechat_redirect" data-linktype="1"><section data-recommend-type="normal" data-recommend-tid="1" data-mid=""><section data-mid=""><section data-mid=""><span><img data-imgfileid="100034418" data-ratio="0.425" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTqjBp2JibLbUv4KBicZiac1iaHBI7PXrI7jp2PXtdJfe1aJHZmamlVwVr8BeT3kLGqCkfMMia1YhxrQ4AA/640?wx_fmt=jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTqjBp2JibLbUv4KBicZiac1iaHBI7PXrI7jp2PXtdJfe1aJHZmamlVwVr8BeT3kLGqCkfMMia1YhxrQ4AA/640?wx_fmt=jpeg"></span></section><section data-mid=""><p data-recommend-title="t" data-mid="">中美两国联手，给华大智造们送了一个大礼包</p></section></section></section></a></section><br><section data-mpa-template="t" data-from="yb-recommend" data-recommend-article-type="normal" data-recomment-template-id="1" data-recommend-article-id="1000001111_1" data-recommend-article-time="1733753226" data-recommend-article-cover="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTqjBp2JibLbUv4KBicZiac1iaHBSVHRvxcUq9FUj9agrMlibTOT3becFMQcO5Dib0RuebD02rhicibM3QtZqw/0?wx_fmt=jpeg" data-recommend-article-title="2420年了，还能涨价？" data-recommend-article-content-url="https://mp.weixin.qq.com/s/o3REb6BHQhPIxQ8Y8pv6-Q"><a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247517830&amp;idx=1&amp;sn=9655b44d0945fdef8854fde727e53812&amp;scene=21#wechat_redirect" data-linktype="1"><section data-recommend-type="normal" data-recommend-tid="1" data-mid=""><section data-mid=""><section data-mid=""><span><img data-imgfileid="100034420" data-ratio="0.42592592592592593" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTqjBp2JibLbUv4KBicZiac1iaHBSVHRvxcUq9FUj9agrMlibTOT3becFMQcO5Dib0RuebD02rhicibM3QtZqw/640?wx_fmt=jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/icugQvAnqxTqjBp2JibLbUv4KBicZiac1iaHBSVHRvxcUq9FUj9agrMlibTOT3becFMQcO5Dib0RuebD02rhicibM3QtZqw/640?wx_fmt=jpeg"></span></section><section data-mid=""><p data-recommend-title="t" data-mid="">2420年了，还能涨价？</p></section></section></section></a></section><br></section><p><strong><br></strong></p><section><ul><li><li><li><li><li><li></ul><pre data-lang="javascript"><code><span>相关资料：</span></code><code><span>注<span>1</span>：https:<span>//chromamedicine.com/2024/12/10/chroma-medicine-and-nvelop-therapeutics-unite-to-form-nchroma-bio-securing-75-million-to-accelerate-genetic-medicines/</span></span></code><code><span>注<span>2</span>：https:<span>//chromamedicine.com/science/#epigenetics-sec</span></span></code><code><span>注<span>3</span>：https:<span>//www.nveloptx.com/</span></span></code><code><span>注<span>4</span>：https:<span>//www.fiercebiotech.com/biotech/two-boston-area-biotechs-shed-staff-fuse-form-genetic-medicines-company-nchroma-bio</span></span></code><code><span><br></span></code></pre></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/K1yst4t6sVWiwPukVDwSIQ",target="_blank" rel="noopener noreferrer">原文链接</a>
